Ledger.Open graph →
SEC Form D · Amendment · filed January 9, 2013

Revance Therapeutics, Inc

Offering
$63.4M
Sold
$63.4M
Exemption
—
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—

People & firms on this filing (16)

Ron Eastman · Newark, CADirectorRichard Teal · Austin, TXDirectorFrank Kung · Newark, CADirectorToney Jennings · Austin, TXDirectorGregory J. Petro · Pittsburgh, PADirectorDan Beecroft · Boca Raton, FLDirectorDaniel M. Teal · Austin, TXDirectorJonathan Tunnicliffe · Newark, CADirectorPhyllis Gardner · Newark, CADirectorRobert Byrnes · Newark, CADirectorBlake Beecroft · Boca Raton, FLDirectorJan Steenbrugge · Boston, MADirectorVicente Trelles · Newark, CADirectorJoel R. Beaudin · North River, NYExec · DirectorJim Glasheen · Newark, CADirectorL. D. Browne · Newark, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗